Navigation Links
Boston Scientific's WATCHMAN® Device Implanted in First Patients in Latin America
Date:11/16/2011

NATICK, Mass., Nov. 16, 2011 /PRNewswire/ -- Boston Scientific Corporation's (NYSE: BSX) WATCHMAN® Left Atrial Appendage (LAA) Closure Device has been implanted in the first patients in Latin America.  The novel device is designed for use in patients in atrial fibrillation who are at risk for stroke and are eligible for long-term oral anticoagulation therapy such as warfarin.  The WATCHMAN LAA Closure Device is intended to prevent embolization of thrombi that may form in the LAA, thereby preventing the occurrence of ischemic stroke and systemic thromboembolism in patients with non-valvular atrial fibrillation.  The first patient implants were performed by Bernardo Caicedo, M.D., Interventional Cardiologist, at Angiografia de Occidente in Cali, Colombia.

Atrial fibrillation, which affects approximately 15 million patients worldwide, is a disorder that disrupts the heart's ability to beat regularly and pump blood efficiently.  Patients in atrial fibrillation are at greater risk for stroke due to the formation and migration of clots in the left atrial appendage.  Anticoagulants such as warfarin have traditionally been the only therapy for reducing stroke risk in these patients.  Boston Scientific's WATCHMAN device is intended to be an alternative to long-term anticoagulation.  It is designed to close the LAA, thereby preventing clots within the appendage from being dislodged into the bloodstream.  

"I am excited to be part of the first patient implants of the WATCHMAN device in Latin America," said Dr. Caicedo.  "The percutaneously delivered device promises to offer a safe and effective alternative for atrial fibrillation patients who cannot take long-term oral anticoagulants and have limited options to reduce their stroke risk.  It incorporates a pre-loaded device that is both repositionable and retrievable to enhance
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
3. Boston University Biomedical Engineers Find Chink in Bacterias Armor
4. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
5. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
7. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
8. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
9. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
10. Award-Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec. 1 for 24-hour Vigil Recognizing World AIDS Day
11. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... Calif., Aug. 4, 2015  Xencor, Inc. (NASDAQ: ... engineered monoclonal antibodies for the treatment of autoimmune ... reported financial results for the second quarter ended June ... business highlights. "Currently eight XmAb® antibody ... and two internal. The accelerating momentum of this ...
(Date:8/4/2015)... DUBLIN , Aug. 04, 2015 ... ) has announced the addition of the ... Patient Comfort and Operational Efficiency, with Growth Driven ... "MRI Systems Market to 2020 - ... Growth Driven by Developing Economies" discusses the market, ...
(Date:8/4/2015)... -- Levi & Korsinsky is investigating the Board of ... BIIB) for possible violations of federal securities laws. The ... and/or directors have violated Sections 10(b) and 20(a) of ... 24, 2015, prior to the opening of the market, ... other things, the Company lowered its prior revenue guidance ...
Breaking Medicine Technology:Xencor Reports Second Quarter 2015 Financial and Operating Results 2Xencor Reports Second Quarter 2015 Financial and Operating Results 3Xencor Reports Second Quarter 2015 Financial and Operating Results 4Xencor Reports Second Quarter 2015 Financial and Operating Results 5Xencor Reports Second Quarter 2015 Financial and Operating Results 6Xencor Reports Second Quarter 2015 Financial and Operating Results 7Xencor Reports Second Quarter 2015 Financial and Operating Results 8Xencor Reports Second Quarter 2015 Financial and Operating Results 9Global MRI Systems Market Outlook to 2020 - Focus on Patient Comfort and Operational Efficiency, with Growth Driven by Developing Economies 2SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation of Biogen Inc. and Its Board of Directors in Connection with Possible Violations of Federal Securities Laws -- BIIB 2
... March 11, 2011 On March 11, 2011, the ... issued a decision as to a portion of the ... CEPH ), ("Cephalon") and its wholly-owned subsidiary CIMA Labs, ... subsidiary Watson Laboratories, Inc., (collectively "Watson") pertaining to Cephalon,s ...
... Wash., March 11, 2011 SCOLR Pharma, Inc. (OTC ... has received a letter from the Food and Drug ... Application (ANDA) for extended-release pseudoephedrine.   The ... that the FDA had with the conduct of the ...
Cached Medicine Technology:Court Rules on First Set of Patents in FENTORA Litigation 2SCOLR Pharma, Inc. Receives Deficiency Letter from FDA on Pseudoephedrine Application 2
(Date:8/4/2015)... ... 04, 2015 , ... An article published July 27th by the ... method for encouraging people to lose weight. Specifically the study compared control patients with ... success, adding a financial incentive to the overall incentive of increased health. According to ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... sweat. Evolutions Medical & Day Spa in Santa Barbara, CA is offering the ... cleared treatment that permanently eliminates sweat and odor glands in the underarms. This ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... Food,” scheduled for Nov. 3 – 4, 2015, at UC San Diego, will ... new businesses, improve food access, and manage resources efficiently against the dueling backdrop ...
(Date:8/4/2015)... Newark, NJ (PRWEB) , ... August 04, 2015 , ... ... higher on quality care metrics – at a cost that is nine percent lower ... Horizon Blue Cross Blue Shield of New Jersey’s patient-centered programs. , “The promise ...
(Date:8/4/2015)... PA (PRWEB) , ... August 04, 2015 , ... ... medical information, checking with “Dr. Google” before calling a physician. In an effort ... is the first health care provider in Pennsylvania to publicly share patient satisfaction ...
Breaking Medicine News(10 mins):Health News:Article on Incentivizing Weight Loss Mirrors Similar Motivations Surrounding Weight Loss Surgery, Says Dr. Feiz & Associates 2Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 2Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 3Health News:Diversity of Urban and Hydroponic Farms of the Future to Highlight Seedstock Annual Conference Field Trip 2Health News:Diversity of Urban and Hydroponic Farms of the Future to Highlight Seedstock Annual Conference Field Trip 3Health News:Horizon BCBSNJ: 2014 Results Show Patient-Centered Care Continues to Deliver on Promise of Better Quality Care at a Lower Cost 2Health News:Horizon BCBSNJ: 2014 Results Show Patient-Centered Care Continues to Deliver on Promise of Better Quality Care at a Lower Cost 3Health News:UPMC 1st in Pa. to Share Provider Ratings 2Health News:UPMC 1st in Pa. to Share Provider Ratings 3
... reduce the use of mechanical ventilation with premature infants ... can profoundly affect those children,s outcomes while reducing the ... at Children,s Hospital Boston. The team, led ... Medicine at Children,s Hospital Boston and the Neonatal Intensive ...
... Daytime sleepiness may affect inhibitory control in the ... research abstract that will be presented Monday, June ... 25th Anniversary Meeting of the Associated Professional Sleep ... daytime sleepiness was associated with decreased activation in ...
... support through group therapy sessions could improve their quality ... patient, a study at The University of Nottingham has ... study into the issue to establish whether psychological therapy ... by the NHS. The study, funded by the ...
... A new study published in the journal Clinical & ... in the home does not increase children,s risk of becoming ... to know whether keeping a dog or cat in their ... to their pets. Led by Ganesa Wegienka, MS, PhD, of ...
... are under intense scrutiny, prompting those in pain ... behind avoidable mortality in legitimately treated patients. Studies ... opioid treatment are now available in a special ... published by Wiley-Blackwell on behalf of the American ...
... older, severely obese patients was not associated with a decreased ... 15 issue of JAMA . This study is being ... AcademyHealth Annual Research Meeting. "Obesity incidence has stabilized ... with a body mass index [BMI] greater than 35 increased ...
Cached Medicine News:Health News:Guidelines for ventilator use help premature infants breathe easier 2Health News:Sleepiness may impair the brain's inhibitory control when viewing high-calorie foods 2Health News:Group therapy helps MS sufferers cope with depression, study finds 2Health News:Group therapy helps MS sufferers cope with depression, study finds 3Health News:Preventing avoidable opioid-related deaths top priority for pain medicine field 2Health News:Preventing avoidable opioid-related deaths top priority for pain medicine field 3Health News:Bariatric surgery among older, high-risk patients not associated with reduced mortality 2
Gentle curve facilitates less traumatic removal from eye. Increased length ideal for myopic eyes...
Great for small incisions and excision needs...
Cannula: .90mm x 28mm (20 G x 1 1/8 in) Handle: 9.3cm (3 5/8 in) long, Flute, .90 x 28mm, vacuum handle [Charles]...
2.5mm...
Medicine Products: